4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-21-020483
Chief Medical Officer sold 1,000 shares at an average $64.56 ($64,556)
- Chief Medical Officer acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ordonez Claudia Chief Medical Officer | 2021-03-11 | Option exercise | +1,000 | $0.48 | $480 | 1,000 | D: show line 1 in the form |
| Ordonez Claudia Chief Medical Officer | 2021-03-11 | Sale | −395 | $64.09 | $25,316 | 605 | D: show line 2 in the form |
| Ordonez Claudia Chief Medical Officer | 2021-03-11 | Sale | −605 | $64.86 | $39,240 | 0 | D: show line 3 in the form |
| Open-market sales · 1,000 sh · avg $64.56 · $64,556 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordonez Claudia Chief Medical Officer | 2021-03-11 | Option exercise · Employee Stock Option (right to buy) | −1,000 | 101,211 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…